Energy deficit: Often around 500-1,000 kcal/day for approximately 0.5-1.0 kg/week loss, this varies between individuals
Some individuals with sensitivities may wish to start with a lower dose
PMID: 39919773 (Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial PubMed) Farr OM, et al
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Industry Leaders Sanofi Eli Lilly Novo Nordisk AstraZeneca Biocon *Disclaimer: Major Players sorted in no particular order Recent Industry Developments March 2023: Eli Lilly announced it would cut the price of its most commonly prescribed insulin products by 70 percent in response to mounting political pressure over the high cost of diabetes medication
In aged mice, it nearly doubles muscle fiber size and enhances muscle stem cell proliferation, resulting in superior muscle regeneration post-injury 1
Many people choose mornings because it fits their schedule, while others prefer evenings to sleep through potential side effects like nausea